Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 23 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase I/II Study of Chemotherapy with Tiazofurin in Adult Patients with ANLL, Nonlymphoid Blast Crisis of CML, Secondary Leukemia, and Advanced Stages of the Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI				IUMC-851130 NCI-T85-0250R, T85-0250

Last Modified: 12/26/2007


2.		Phase I/II Pilot Study of Tiazofurin in Adults with AML, ALL, Nonlymphoid Blast Crisis of CML, Secondary AML, and Advanced Stage Myelodysplastic Syndrome

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 to 75				NCI				IUMC-890117 NCI-T88-0075O, T88-0075

Last Modified: 6/1/1989


3.		Phase I/II Study of Tiazofurin in Patients with CML in Blast Crisis (Summary Last Modified 06/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				15 and over				NCI				MDA-DM-88108 NCI-T88-0198C, T88-0198

Last Modified: 4/1/1998


4.		Phase II Study of Tiazofurin in Patients with CML in Blast Crisis (Summary Last Modified 04/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 to 80				NCI				BUMC-3333 NCI-T90-0213O, T90-0213


5.		Phase II Chemotherapy with Tiazofurin in Patients with Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 and over				NCI				MDA-DM-8420 NCI-T84-0369D, T84-0369


6.		Phase II Chemotherapy with Tiazofurin for Recurrent Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				15 and over				NCI				MDA-DM-8516 NCI-T84-0421C, T84-0421


7.		Phase II Chemotherapy with Tiazofurin in Patients with Unresectable Recurrent or Metastatic Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified								MAOP-8185


8.		Phase II Chemotherapy with Tiazofurin in Patients with Advanced non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								CAN-NCIC-IND11 NCI-T85-0019W, T85-0019, IND11


9.		Phase II Chemotherapy with Tiazofurin in Patients with Advanced Colorectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								CAN-NCIC-IND9 NCI-T85-0018W, T85-0018, IND9


10.		Phase II Chemotherapy with Tiazofurin in Patients with Refractory Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								CAN-NCIC-IND10 NCI-T85-0101W, T85-0101, IND10

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute